Document is current
Any future updates will be listed below
-
Authors
Leonard, Helen
Szepe, Emma
Junaid, Mohammed
Wong, Kingsley
Saldaris, Jacinta
Downs, Jenny
-
Funding
Funding for this research was provided by:
International Foundation for CDKL5 Research
Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania (CDKL5-19-D-101-3)
Stan Perron Charitable Foundation (Fellowship)
- License Information
-
More Information
Article History
Received: 4 April 2024
Accepted: 25 November 2025
First Online: 2 January 2026
Declarations
:
: The Human Research Ethics Committee of the University of Western Australia provided approval for this study in accordance with the Declaration of Helsinki.
: Written or electronic informed consent was obtained from the caregivers of individuals whose data was used in the study.
: HL provided consultancy for Marinus Pharmaceuticals, Acadia Pharmaceuticals, Novartis Gene Therapies and Orion Corporation; and clinical trials with Anavex Life Science and Newron Pharmaceuticals. All consultancies are unrelated to this work, and all remuneration has been made to her department.JD provided consultancy for Marinus Pharmaceuticals, Neurogene, Ultragenyx Pharmaceutical, Acadia Pharmaceuticals, Novartis Gene Therapies, Orion Corporation and Taysha Gene Therapies; and clinicaltrials with Anavex Life Science and Newron Pharmaceuticals. All consultancies are unrelated to this work, andall remuneration has been made to her department.
